Efficacy of NIV Masks in COPD
Not Applicable
Completed
- Conditions
- COPD
- Interventions
- Device: Investigation MaskDevice: Comparator Mask
- Registration Number
- NCT04947852
- Lead Sponsor
- Fisher and Paykel Healthcare
- Brief Summary
A randomized controlled pilot study to compare the efficacy and tolerability of a two different NIV masks on carbon dioxide in participants with stable chronic obstructive pulmonary disease (COPD) with chronic type II respiratory failure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
- A doctor's diagnosis of COPD
- PtCO2 ≥45mmHg on transcutaneous monitor at baseline measure
- Oxygen saturation measured by pulse oximetry (SpO2) ≥85%
- Fits the study mask
- Can tolerate the therapy
Exclusion Criteria
- FEV1/FVC ≥70%
- Body mass index >35
- Hypercapnia considered to be primarily due to Obesity Hypoventilation syndrome and/or Obstructive Sleep Apnea
- Any condition which makes NIV contra-indicated as per BTS guidelines based on clinical judgement
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Investigation Mask Comparator Mask Bi Level CPAP Mask Comparator Mask Comparator Mask Bi Level CPAP Mask Comparator Mask Investigation Mask Bi Level CPAP Mask Investigation Mask Investigation Mask Bi Level CPAP Mask
- Primary Outcome Measures
Name Time Method Transcutaneous Carbon Dioxide 60 minutes mmHg
- Secondary Outcome Measures
Name Time Method Minute Ventilation 60 minutes Litres
Respiratory Rate 60 minutes Breaths per minute
Oxygen Saturation 60 minutes Percentage
Heart Rate 60 minutes Beats per minute
Borg Dyspnoea Score 60 Minutes 1-6 Ranking, with 1 being best and 6 being worst
Trial Locations
- Locations (1)
Medical Research Institute New Zealand
🇳🇿Wellington, New Zealand